CIK: 0002010850 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $573,196 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 6,371,669 | $256,651 | 44.8% | $39.91 | -27.2% | COM | 156944100 |
| NUVB | Nuvation Bio Inc. | 25,954,439 | $96,031 | 16.8% | $3.05 | -10.7% | COM | 67080N101 |
| UPB | Upstream Bio Inc. | 3,285,293 | $61,796 | 10.8% | $22.33 | -30.4% | COM | 91678A107 |
| AARD | AARDVARK THERAPEUTICS INC | 3,917,299 | $52,061 | 9.1% | $11.23 | +0.4% | COM | 002942100 |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 657,051 | $18,687 | 3.3% | $19.66 | +21.9% | COM | N62509109 |
| — | MERUS NV | 186,546 | $17,563 | 3.1% | $51.07 | — | COM | N5749R100 |
| RVMD | REVOLUTION MEDICINES INC(NSM) | 210,000 | $9,807 | 1.7% | $50.40 | -22.3% | COM | 76155X100 |
| — | Lyell Immunopharma, Inc. | 595,466 | $9,670 | 1.7% | $0.64 | — | COM | 55083R104 |
| BYSI | BeyondSpring Inc. | 4,286,104 | $7,758 | 1.4% | $0.92 | +113.3% | SHS | G10830100 |
| ACRS | Aclaris Therapeutics, Inc. | 4,041,736 | $7,679 | 1.3% | $2.33 | -25.2% | COM | 00461U105 |
| RCUS | Arcus Biosciences, Inc | 547,609 | $7,447 | 1.3% | $12.03 | -13.6% | COM | 03969F109 |
| EQ | Equillium Inc. | 4,447,308 | $6,360 | 1.1% | $0.59 | +77.9% | COM | 29446K106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 143,000 | $5,956 | 1.0% | $39.97 | -20.0% | COM | 22663K107 |
| KRYS | KRYSTAL BIOTECH INC | 32,300 | $5,702 | 1.0% | $122.01 | +22.7% | COM | 501147102 |
| AURA | Aura Biosciences, Inc. | 515,555 | $3,186 | 0.6% | $8.47 | -22.8% | COM | 05153U107 |
| ZNTL | Zentalis Pharmaceuticals Inc. | 1,323,327 | $1,998 | 0.3% | $13.39 | -88.8% | COM | 98943L107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 181,600 | $1,302 | 0.2% | $50.17 | — | COM | G4444C102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 92,748 | $806 | 0.1% | $24.39 | -75.5% | COM | 35104E100 |
| ILMN | Illumnia, Inc. | 7,979 | $758 | 0.1% | $122.34 | -18.9% | COM | 452327109 |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | $726 | 0.1% | $1.71 | -15.9% | COM | 747324101 |
| GRAL | GRAIL INC | 9,684 | $573 | 0.1% | $16.22 | +135.6% | COM | 384747101 |
| RZLT | REZOLUTE INC | 59,900 | $563 | 0.1% | $3.71 | +79.3% | COM | 76200L309 |
| — | Nuvation Bio Inc. | 646,057 | $115 | 0.0% | $0.16 | — | WARRANTS | 67080N119 |